| 5088 |
Centers for Disease Control and Prevention |
Html |
en |
Science Clips - Monday, April 12, 2010 |
null |
| Apr | 0.712236 |
| total blood volume | 0.67991 |
| Intermittent preventive treatment | 0.676296 |
| PLoS ONE. | 0.745366 |
| serum cotinine levels | 0.678989 |
| CDC Knowledge | 0.73233 |
| passive immune therapy | 0.6746 |
| Hunter New England | 0.683143 |
| Action Science Clips | 0.971953 |
| Community Dent Oral | 0.678945 |
| fulminant bacterial infections | 0.674061 |
| new weekly digest | 0.695343 |
| social marketing intervention | 0.679115 |
| State cigarette minimum | 0.674041 |
| Northern New South | 0.687862 |
| body mass index | 0.683795 |
| Chief Science Officer | 0.696806 |
| high body mass | 0.697647 |
| State cigarette excise | 0.676539 |
| VZV Nomenclature Meeting | 0.68083 |
| HIV type | 0.676484 |
| cancer news coverage | 0.760944 |
| Defects Prevention Study | 0.69289 |
| news coverage trends | 0.749588 |
| Clin Chim Acta. | 0.694785 |
|
| type 1-infected patients | 0.686327 |
| planned behavior perspective | 0.670303 |
| Stephen B. Thacker | 0.76838 |
| Plasmodium falciparum multidrug | 0.684739 |
| Yanovski JA | 0.673337 |
| Proc Natl Acad | 0.67902 |
| ter Kuile FO | 0.682318 |
| Lyme disease agent | 0.677967 |
| comprehensive content analyses | 0.751425 |
| Serotype specific antisera | 0.680224 |
| HIV Outpatient Study | 0.689503 |
| rural Western Kenya | 0.674489 |
| Patient Educ Couns. | 0.675236 |
| newly diagnosed HIV | 0.679352 |
| Multiple genetic backgrounds | 0.677348 |
| species varicella-zoster virus | 0.678581 |
| potential human health | 0.692755 |
| double-blind placebo-controlled trial | 0.681529 |
| public health literature | 0.693747 |
| B. Thacker CDC | 0.806041 |
| et al | 0.674303 |
| study National Birth | 0.693052 |
| national survey data | 0.691183 |
| Thacker CDC Library | 0.806025 |
|
CLICK HERE |
| 5549 |
Centers for Disease Control and Prevention |
Html |
en |
p-Phenylene diamine - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 5809 |
Centers for Disease Control and Prevention |
Html |
en |
Propylene dichloride - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 8987 |
Centers for Disease Control and Prevention |
Video |
en |
CDC: Tips From Former Smokers - Tiffany: You Don't Quit Just for Yourself |
Tiffany talks about losing her mother, a smoker, to lung cancer when she was 16. Despite this, Tiffany smoked for years before realizing what she might miss in her own daughter's life. In this video from CDC's Tips From Former Smokers campaign, Tiffany's daughter's, Jaelin, says she cannot imagine living without her mother. Jaelin goes on to tell her mom how proud she is of her for quitting smoking for good.
Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html
This video can also be viewed at
http://streaming.cdc.gov/vod.php?id=ff67b50b6de6064f26c7bb347d2aa68f20130326152816255 |
| Tiffany | 0.974332 |
| Smokers | 0.996151 |
|
| CDC | 0.979113 |
| YouTube | 0.926248 |
|
CLICK HERE |
| 10431 |
Centers for Disease Control and Prevention |
Html |
en |
Roadmap for State Program Planning - Tools'State Resources'DHDSP'CDC |
null |
| track health objectives | 0.595512 |
| BRFSS core health | 0.619911 |
| tool create online | 0.549584 |
| health promotion projects | 0.582245 |
| stroke mortality rates | 0.769406 |
| high blood cholesterol | 0.545036 |
| social determinants | 0.532768 |
| health topics | 0.5317 |
| evaluation plan | 0.538399 |
| congestive heart failure | 0.579325 |
| best practice programs | 0.538676 |
| national monitoring data | 0.553167 |
| National Center | 0.542361 |
| Partnerships Analysis Tool | 0.62532 |
| Stroke Statistics | 0.571663 |
| data collection program | 0.567025 |
| heart disease statistics | 0.688845 |
| Stroke Treatment Program | 0.612033 |
| American Heart Association | 0.601472 |
| Health Maps | 0.542437 |
| Health Statistics | 0.589806 |
| Chronic Disease Cost | 0.590778 |
| health problems | 0.532857 |
| current county-level variables | 0.559807 |
| Stroke Prevention Management | 0.618575 |
|
| Behavioral Risk Factor | 0.53794 |
| heart disease death | 0.659176 |
| public domain software | 0.541368 |
| health promotion | 0.63641 |
| CDC HDSP Program | 0.552327 |
| Community Tool Box | 0.55862 |
| stroke prevention programs | 0.754572 |
| heart disease | 0.948698 |
| Survey Generation Tool | 0.549882 |
| county heart disease | 0.636685 |
| public health professionals | 0.597239 |
| Gantt chart-based project | 0.542994 |
| CDC Heart Disease | 0.646107 |
| Metropolitan/Micropolitan Area Risk | 0.548198 |
| ASTP guides hospitals | 0.542125 |
| Primary Stroke Center | 0.607947 |
| primary health care | 0.576283 |
| chronic disease programs | 0.580637 |
| in-hospital resuscitation teams | 0.53831 |
| prevention programs development | 0.57667 |
| high blood pressure | 0.535309 |
| Wizard (PEW) | 0.544843 |
| Community Preventive Services | 0.533652 |
| coronary heart disease | 0.62738 |
|
CLICK HERE |
| 11745 |
Centers for Disease Control and Prevention |
Html |
en |
Norovirus | Reporting and Surveillance | CDC |
Reporting and surveillance of norovirus utilizing NORS and CalicNet |
| norovirus outbreaks | 0.953408 |
| Public health agencies | 0.352689 |
| United States | 0.342611 |
| national surveillance | 0.234475 |
| current norovirus outbreak | 0.465697 |
| CDC surveillance systems | 0.442383 |
| norovirus outbreak | 0.566914 |
| territorial health departments | 0.418576 |
| monitor norovirus strains | 0.480894 |
| norovirus outbreak surveillance | 0.537489 |
| norovirus illness | 0.686194 |
| territorial health department | 0.374856 |
| state health departments | 0.564169 |
| new strains | 0.268574 |
| health departments | 0.696515 |
|
| Health care providers | 0.367036 |
| acute gastroenteritis | 0.262205 |
| surveillance network | 0.445316 |
| assess strain-specific characteristics | 0.293939 |
| Vaccine Surveillance Network | 0.338513 |
| norovirus outbreak reporting | 0.472749 |
| doctor’s offices | 0.200872 |
| local public health | 0.339475 |
| National Outbreak Reporting | 0.463785 |
| Norovirus Sentinel Testing | 0.367545 |
| outbreak frequency | 0.266077 |
| public health laboratories | 0.598862 |
| laboratory data | 0.320977 |
| Active Surveillance Network | 0.339337 |
|
CLICK HERE |
| 12314 |
Centers for Disease Control and Prevention |
Html |
en |
Diagnostic Criteria | Autism Spectrum Disorder (ASD) |NCBDDD |
Autism Spectrum Disorders (ASDs) are a group of developmental disabilities that can cause significant social, communication and behavioral challenges. CDC is working to find out how many children have ASDs, discover the risk factors, and raise awareness of the signs. |
| various social contexts | 0.553295 |
| total lack | 0.47684 |
| multiple contexts | 0.481886 |
| repetitive patterns | 0.599819 |
| American Psychiatric Association | 0.654921 |
| Persistent deficits | 0.523961 |
| clinically significant impairment | 0.528563 |
| autistic disorder | 0.480563 |
| intellectual developmental disorder | 0.54813 |
| repetitive motor movements | 0.541237 |
| body language | 0.47709 |
| nonverbal communicative behaviors | 0.564562 |
| well-established DSM-IV diagnosis | 0.524018 |
| inflexible adherence | 0.472372 |
| excessive smelling | 0.471785 |
| simple motor stereotypes | 0.530327 |
| global developmental delay | 0.530203 |
| social demands | 0.483476 |
| language impairment | 0.471929 |
| small changes | 0.471096 |
| social interaction | 0.554599 |
| imaginative play | 0.473266 |
| comorbid diagnoses | 0.475026 |
| autism spectrum disorder | 0.921987 |
|
| abnormal social approach | 0.564602 |
| current severity | 0.558913 |
| social communication impairments | 0.658088 |
| normal back-and-forth conversation | 0.540522 |
| nonverbal communication | 0.547329 |
| genetic condition | 0.527927 |
| social communication | 0.738107 |
| social interactions | 0.493885 |
| facial expressions | 0.473098 |
| standardized criteria | 0.479676 |
| pervasive developmental disorder | 0.543439 |
| Statistical Manual | 0.477887 |
| comorbid catatonia | 0.493913 |
| intellectual impairment | 0.47715 |
| rigid thinking patterns | 0.527117 |
| early developmental period | 0.532943 |
| social-emotional reciprocity | 0.487028 |
| Coding note | 0.571099 |
| e.g. apparent indifference | 0.53124 |
| behavioral disorder | 0.51469 |
| nonverbal behavior | 0.492054 |
| eye contact | 0.478519 |
| additional code | 0.574808 |
|
CLICK HERE |
| 13107 |
Centers for Disease Control and Prevention |
Html |
en |
About Our Office | CDC Funding |
null |
| Office | 0.232869 |
| tools people | 0.39634 |
| financial resources | 0.950229 |
| applicable laws | 0.359765 |
| proud contributions | 0.351901 |
| sound business practices | 0.547338 |
| CDC’s acquisition | 0.579659 |
| effective customer service | 0.561773 |
| public health outcomes | 0.58103 |
| essential role | 0.397447 |
| acquisition processes | 0.546418 |
| public funds | 0.350879 |
|
| public health | 0.851507 |
| CDC/ATSDR financial resources | 0.608695 |
| exceptional customer service | 0.657713 |
| CDC’s mission | 0.531486 |
| public health missions | 0.617989 |
| fiscal stewardship | 0.37164 |
| implements policies | 0.356691 |
| Resources (OFR) | 0.659176 |
| diverse workforce | 0.348663 |
| exemplary customer-focused leadership | 0.604171 |
| public health science | 0.596567 |
| agency-wide financial management | 0.634339 |
|
CLICK HERE |
| 15944 |
Centers for Disease Control and Prevention |
Html |
en |
Vaccination Coverage Among Children in Kindergarten - UnitedStates, 2015-16 School Year | MMWR |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| complete vaccination | 0.250263 |
| nonmedical exemptions | 0.303544 |
| median MMR coverage | 0.239456 |
| data | 0.680109 |
| catch-up vaccination schedule | 0.2624 |
| exemption | 0.44916 |
| New York City | 0.289999 |
| vaccination coverage | 0.96494 |
| period/provisional enrollment data | 0.278972 |
| school | 0.616396 |
| medical exemptions | 0.337576 |
| children | 0.294751 |
| kindergartners | 0.385646 |
| median exemption rate | 0.296183 |
| vaccination assessments | 0.257926 |
| varicella vaccine | 0.444936 |
| school entry | 0.37222 |
| acellular pertussis vaccine | 0.306489 |
| median vaccination coverage | 0.320837 |
| vaccination coverage data | 0.314113 |
| private school data | 0.24665 |
| school vaccination coverage | 0.314544 |
| provisional enrollment | 0.690162 |
| kindergarten vaccination | 0.313815 |
| grace period | 0.661534 |
|
| schools | 0.297357 |
| Median vaccination coverage* | 0.261228 |
| state-level vaccination coverage | 0.259599 |
| rubella vaccines | 0.296301 |
| high vaccination coverage | 0.240174 |
| doses | 0.548004 |
| MMR coverage | 0.356631 |
| vaccination requirements | 0.250466 |
| public school data | 0.361154 |
| states | 0.813703 |
| percentage points | 0.315128 |
| kindergarten vaccination data | 0.300031 |
| immunization programs | 0.443042 |
| rubella vaccine | 0.295852 |
| exemptions | 0.529276 |
| grace period/provisional enrollment | 0.524925 |
| 50 states | 0.37992 |
| missing vaccine doses | 0.250586 |
| varicella vaccine coverage | 0.240056 |
| DTaP vaccine | 0.23939 |
| median kindergarten vaccination | 0.244831 |
| vaccine | 0.450889 |
| exemption data | 0.372796 |
| vaccine-preventable diseases | 0.262809 |
|
CLICK HERE |
| 16073 |
Centers for Disease Control and Prevention |
Html |
en |
National Progress Toward Hepatitis C Elimination - Georgia,2015-2016 | MMWR |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| HCV treatment | 0.56574 |
| HCV antibodies | 0.28565 |
| HCV RNA | 0.306626 |
| HCV infection | 0.907089 |
| Social Affairs | 0.20856 |
| advanced liver disease | 0.258945 |
| HCV treatment program | 0.365443 |
| HCV infection worldwide | 0.415825 |
| comprehensive HCV elimination | 0.421319 |
| HCV screening | 0.326913 |
| HCV care | 0.297472 |
| HCV diagnostics | 0.283293 |
| HCV genotype | 0.293302 |
| inadequate infection control | 0.200435 |
| HCV elimination plan | 0.441439 |
|
| Elimination Program Treatment | 0.263241 |
| liver disease | 0.260084 |
| direct-acting antiviral HCV | 0.332536 |
| HCV treatment services | 0.376926 |
| patients | 0.225751 |
| elimination program progresses | 0.202816 |
| HCV infection prevalence | 0.381903 |
| positive HCV antibody | 0.328124 |
| Program Treatment Database | 0.235293 |
| persons | 0.201316 |
| hcv elimination program | 0.887101 |
| infectious disease specialists | 0.203588 |
| treatment centers | 0.204422 |
| active HCV infection | 0.415688 |
| laboratory-based HCV antibody | 0.330053 |
|
CLICK HERE |